ClinicalTrials.gg
Not yet recruitingNCT07220434Updated Oct 23, 2025

TO Plate Fixation vs. External Fixator Comparison (HTO Plate vs. ExFix Study)

An interventional study of Medial HTO Locking Plate and Self-Adjusting HTO External Fixator in Medial Compartment Osteoarthritis, Genu Varum and Varus Deformity, sponsored by Muhammed Cagatay Engin. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-10-23.

Sponsored by Muhammed Cagatay Engin · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to compare the efficacy, accuracy, and functional outcomes of two different surgical stabilization techniques for medial opening wedge high tibial osteotomy (HTO) in patients with varus deformity and medial compartment osteoarthritis. Patients will be prospectively randomized into two groups: Group 1 (Plate Fixation) will receive acute (single-stage) correction and stabilization with a medial HTO locking plate. Group 2 (HTO External Fixator) will receive stabilization using a self-adjusting HTO external fixator, followed by gradual correction (hemicallotasis/distraction) starting 7 days post-operatively. The study will evaluate radiological correction, functional improvement (using the Oxford Knee Score), and complication rates over a 12-month follow-up period.

02

Conditions studied

  • Medial Compartment Osteoarthritis
  • Genu Varum
  • Varus Deformity
  • High Tibial Osteotomy

Browse trials for

03

In context

Genu Varum

18 studies on the registry are indexed under Genu Varum; 8 are open to participants now.

This study's planned enrollment of 28 is below the median of 60 across 12 interventional studies indexed under Genu Varum.

Browse Genu Varum studies →

Lead sponsor

This is the only study on the registry with Muhammed Cagatay Engin as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Varus malalignment associated with medial compartment degeneration/osteoarthritis.

Indication for Medial Opening Wedge HTO. Aged 18 years or older. Willing to participate in the study and provide written .

Exclusion criteria

Exclusion Criteria:

  • Advanced-stage osteoarthritis (Indication for Total Knee Arthroplasty). Previous open knee surgery on the same extremity. Inability to comply with follow-up appointments. Significant comorbidities (e.g., uncontrolled diabetes, rheumatoid arthritis).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
28 participants (estimated)

Study arms

  • Experimental
    Group 1: Plate Fixation

    The osteotomy will be acutely corrected intraoperatively and stabilized using a Medial High Tibial locking plate.

    Device: Medial HTO Locking Plate

  • Active comparator
    Group 2: HTO External Fixator

    he osteotomy will be stabilized using a Self-Adjusting HTO External Fixator. Gradual distraction (hemicallotasis) will begin 7 days post-operatively at a rate of 1 mm per day to achieve correction.

    Device: Self-Adjusting HTO External Fixator

Interventions

  • DeviceMedial HTO Locking Plate

    Medial Opening Wedge High Tibial Osteotomy.

  • DeviceSelf-Adjusting HTO External Fixator

    Medial Opening Wedge High Tibial Osteotomy.

06

What researchers measure

Primary outcomes

  1. Change in Radiological Correction (Hip-Knee-Ankle Angle - HKA)

    ssessment of the mechanical axis on full-length weight-bearing radiographs (Measured in degrees).

    Time frame: Baseline (Preoperative), 6 Weeks, 3 Months, 6 Months, and 12 Months Postoperative.

  2. Change in Functional Status (Oxford Knee Score - OKS)

    Patient-reported functional score assessing pain and knee function.

    Time frame: Baseline (Preoperative), 6 Weeks, 3 Months, 6 Months, and 12 Months Postoperative.

  3. Change in Pain Intensity (Visual Analogue Scale - VAS)

    Patient-reported pain score from 0 (no pain) to 10 (intolerable pain).

    Time frame: Baseline (Preoperative), 6 Weeks, 3 Months, 6 Months, and 12 Months Postoperative

Secondary outcomes

  1. Change in Femoro-Tibial Angle (FTA)

    Change in the anatomical axis measured in degrees.

    Time frame: Baseline (Preoperative) and 12 Months Postoperative.

  2. Change in Mechanical Axis Percentage (MA%)

    Change in the position of the weight-bearing line on the tibial plateau.

    Time frame: Baseline (Preoperative) and 12 Months Postoperative.

  3. Change in Posterior Tibial Slope (PTE)

    Change in the tibial slope measured in degrees.

    Time frame: Baseline (Preoperative) and 12 Months Postoperative.

  4. Change in Patellar Height (Insall-Salvati Index)

    Change in patellar height measured by the Insall-Salvati ratio.

    Time frame: Baseline (Preoperative) and 12 Months Postoperative.

  5. Incidence of Complications

    Incidence of adverse events including pin tract infection (especially Group 2), superficial or deep infection, non-union/delayed union, lateral cortex fracture, hardware exposure, or knee stiffness.

    Time frame: Up to 12 months postoperative.

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2025; primary completion for Dec 2028, 37 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 22, 2025
First posted
Oct 23, 2025
StartEst.
Nov 15, 2025
Primary completionEst.
Dec 31, 2028
CompletionEst.
Dec 31, 2028
Last update
Oct 23, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 23, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07220434
Lead sponsor
Muhammed Cagatay Engin
Responsible party
Muhammed Cagatay Engin (Associate Professor, Ataturk University) — Sponsor-investigator
First posted
Oct 23, 2025
Start date
Nov 15, 2025 (estimated)
Primary completion
Dec 31, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Oct 23, 2025

Study contacts

ali afşar, md
Contact
afsarali1708@gmail.com
+905374927543

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion